| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |